Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
07/2008
07/31/2008US20080182279 Bacillus crystal protein having improved insecticidal activity; transgenic plant; polynucleotide segment having a sequence region that encodes an insecticidal hybrid delta-endotoxin protein; immunoassay
07/31/2008US20080182278 Identification and isolation of transitional cell carcinoma stem cells
07/31/2008US20080182277 Assays and methods using biomarkers
07/31/2008US20080182276 Method and Quantification Assay for Determining c-kit/SCF/pAKT Status
07/31/2008US20080182275 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/31/2008US20080182274 Measuring simply and rapidly the expression of membrane protein on cell membrane; promotion/inhibition of the expression of membrane proteins
07/31/2008US20080182273 allowed to mix by diffusion without convective flow across the interface; protein crystallization system; gradual and non-directional mixing, avoiding asymmetries and steep concentration gradients associated with convective flow between the fluids
07/31/2008US20080182272 Rapid resuscitation, growth, capture and detection of microorganisms
07/31/2008US20080182271 Identifying modulators of microtubule polypeptide; antiproliferative agents; drug screening
07/31/2008US20080182266 Trp8, a transient receptor potential channel expressed in taste receptor cells
07/31/2008US20080182262 simultaneous determination of the activation states of a plurality of proteins in single cells. This approach permits the rapid detection of heterogeneity in a complex cell population based on activation states, and the identification of cellular subsets that exhibit correlated changes
07/31/2008US20080182261 detecting the presence or absence of the fetal DNA sequence of interest in fetal DNA derived from a sample of peripheral blood obtained from a pregnant woman is described. The method involves obtaining a sample peripheral blood from a pregnant woman, treating the sample of peripheral blood
07/31/2008US20080182255 Gene Expression Profiling in Biopsied Tumor Tissues
07/31/2008US20080182248 Parallel genotyping of multiple patient samples
07/31/2008US20080182239 nucleic acids, compositions, and kits for detecting microRNA (miRNA) in samples. The methods comprise designing mRNA-specific primers, adding a polyA tail to the miRNA, and using reverse transcription and amplification to detect the miRNA. The nucleic acids, compositions, and kits
07/31/2008US20080182238 conducting a biochemical assay that allows for a reduction of assay interferences. The method comprises treating a mixture of cell sample and cell constituents solubilizing agent, with an insoluble agent prior to conducting the assay. There is also provided a device as well as a kit for analyzing
07/31/2008US20080182235 Incubating a luminescence-related amplificant encapsulated within said liposomes, a buffer and paramagnetic beads; separating; treating with extractant; measuirng emitted light from assay sample; early detection of disease-causing microorganisms
07/31/2008US20080182234 Methods and Compositions for Modulating Adenosine Triphosphate (ATP) in Cells and Preventing Cell Injury or Death via Post-translational Modifications to ATP Synthase
07/31/2008US20080182056 Hollow Microsphere Particles
07/31/2008US20080181965 polymeric particles made of copolymeric butyl acrylate, divinylbenzene, ethylstyrene, and poly(ethylene glycol) monomethyl ether methacrylate conjugated with peptide; protein; polysaccharide; nucleotide; oligonucleotide; nucleic acid; hapten; drug; biocompatible, resistant to adhesion of serum protein
07/31/2008US20080181918 Immunogens; vaccines; fusion proteins
07/31/2008US20080181908 Genes and proteins, and their use
07/31/2008US20080181907 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia
07/31/2008US20080181902 Mutant protofibril for active immunisation; synuclein genes, proteins; Parkinson's disease; dementia
07/31/2008US20080181896 Selections of genes and methods of using the same for diagnosis and for targeting the therapy of select cancers
07/31/2008US20080181895 SP16 protein
07/31/2008US20080181894 Tumor/cancer antigens; solid phase synthesis; drug screening
07/31/2008US20080181889 antagonist of epithelial membrane protein-2, blocking the entry of Chlamydia into the host cell; biodrug for treating gramnegative bacteria intracellular prokaryotic pathogens; drug screening
07/31/2008US20080181885 202P5A5 gene or fragment or its encoded protein, or variants , or a fragment, used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 202P5A5 be used in active or passive immunization; gene therapy, immunotherapy; anticarcinogenic agent biodrug for pancreatic cancer
07/31/2008US20080181884 administering a synergistic mixture comprising an antibody, Anidulafungin (LY303366) and amphotericin B; for drug resistanct infections; induce immunology response; diagnosis of a patient with a Coccidioidomycosis infection
07/31/2008US20080181883 Purified Antigen for Alzheimer's Disease and Methods of Obtaining and Using Same
07/31/2008US20080181882 treating a neuropsychiatric disorder with siRNA, polyamides, antisense RNA, synthetic peptide nucleic acids, antibody, Fab fragment; enhancing tyrosine phosphorylation; long lasting treatment, inhibit side effects; biodrugs; gene therapy; drug screening
07/31/2008US20080181881 drug screening a polypeptide antagonist or antibody that binds to the acid-sensing ion channel 3; antisense nucleic acid that inhibit or decreases the expression level of the acid-sensing ion channel 3; treating glucose intolerance of metabolic disorders
07/31/2008US20080181865 Methods of treating neurological conditions with hematopoeitic growth factors
07/31/2008US20080181864 Reducing mitochondrial membrane potential in mammalian cell by administering an major histocompatibility complex (MHC) class II HLA-DR (human leukocyte antigen) ligand; control disease by manipulating mitochondrial metabolism; drug screening antitumor drug; treating human breast cancer
07/31/2008US20080181850 detecting the presence or absence of expression neuroligin messenger RNA or polypeptides in tumor tissues or blood of humans suspected of having prostate cancer; screening for antisense agents or drugs; medical diagnosis
07/31/2008US20080181849 Methods, kits and compositions comprising crotamine
07/31/2008US20080181848 Method to detect dopamine receptors in the functional d2high state
07/31/2008US20080181834 Method for screening microcrystallizations for crystal formation
07/31/2008US20080181827 Method and system implementing spatially modulated excitation or emission for particle characterization with enhanced sensitivity
07/31/2008US20080181819 high flow properties and a low dead volume; integrated system that comprises molecular traps, such as affinity microcolumns, derivatized mass spectrometer targets, mass spectrometers capable of multi-sample input and robotics with processing/data analysis interactive database software
07/31/2008US20080180692 Method and apparatus for assay based on light diffraction
07/31/2008US20080180652 Test element analysis system
07/31/2008US20080179196 Detection of analytes using reorganization energy
07/31/2008US20080178663 Adaptive real-time contaminant detection and early warning for drinking water distribution systems
07/31/2008DE102007039316B3 Analysis apparatus for gaseous mixtures of fuel and air fed to burners for glass treatment vessels removes part of the gas and burns it in chamber in vessel wall, exhaust gases being passed to oxygen sensor
07/31/2008DE102007003755A1 Bahnförmiges Material mit einer Beschichtung, die ein dauerhaftes schnelles Spreiten beziehungsweise einen dauerhaften sehr schnellen Transport von Flüssigkeiten ermöglicht Web-like material with a coating which allows sustained rapid spreading or lasting very rapid transport of liquids
07/31/2008DE102007003341A1 Okularsensor zum Nachweis eines Analyten in einer Augenflüssigkeit Ocular sensor for detecting an analyte in an ocular fluid
07/31/2008DE102006009450B4 Verfahren zur Qualitätssicherung bei der Papierherstellung Procedures for quality assurance in papermaking
07/31/2008DE102005011003B4 Verfahren und Mittel zur differentiellen Diagnose von Schilddrüsentumoren Method and means for the differential diagnosis of thyroid tumors
07/31/2008DE102005005333B4 Verfahren zur Probennahme und Aerosol-Analyse Methods for sampling and analysis of aerosol
07/31/2008CA2855425A1 Method for influencing the properties of cast iron
07/31/2008CA2676611A1 Methods and compositions for depleting specific cell populations from blood tissues
07/31/2008CA2676436A1 Diagnosis of prostate cancer
07/31/2008CA2676329A1 Detecting analytes using both an optical and an electrical measurement method
07/31/2008CA2676148A1 Methods of detecting autoantibodies for diagnosing and characterizing disorders
07/31/2008CA2676091A1 Methods and biomarkers for diagnosing and monitoring psychotic disorders
07/31/2008CA2676017A1 Zinc-based screening test and kit for early diagnosis of prostate cancer
07/31/2008CA2675776A1 Specific n-terminal labeling of peptides and proteins in complex mixtures
07/31/2008CA2675618A1 Factor h polymorphisms in the diagnosis and therapy of inflammatory diseases such as age-related macular degeneration
07/31/2008CA2675521A1 Human cancer stem cells
07/31/2008CA2675293A1 Cancerous disease modifying antibodies
07/31/2008CA2675292A1 Cancerous disease modifying antibodies
07/31/2008CA2674897A1 Cancerous disease modifying antibodies
07/31/2008CA2674021A1 Method for assaying antibodies in body fluids by immune reaction with glycoprotein 2 (gp2) from zymogenic granules of the pancreas for the differential diagnosis of inflammatory intestinal diseases and chronic pancreatitis
07/31/2008CA2673783A1 Water detection and 3-phase fraction measurement systems
07/31/2008CA2673782A1 Sorting of microdevices
07/31/2008CA2671866A1 Analysis chip and analysis method
07/31/2008CA2671298A1 Use of igfbp-7 in the assessment of heart failure
07/31/2008CA2666662A1 Methods to utilize invertebrate chemosensory proteins for industrial and commercial uses
07/30/2008EP1950567A1 Apparatus for monitoring thrombus formation and method of monitoring thrombus formation
07/30/2008EP1950566A1 Method of evaluating binding properties of biosubstances and biosubstance-binding substances
07/30/2008EP1950565A1 Method of assaying antigen and kit to be used therein
07/30/2008EP1950564A1 Mutiple immunochemistry assays on an element
07/30/2008EP1950563A2 Method for screening for a substance for promoting regeneration of macrophages
07/30/2008EP1950562A2 Integrated sample testing meter
07/30/2008EP1950561A1 Contactless control of the stiffness of wood products in the production line
07/30/2008EP1950560A1 Method and device for the quantitative analysis of gases in a transformer oil
07/30/2008EP1950310A1 Method for risk prediction of a postoperative sepsis in a human
07/30/2008EP1950309A1 Albumin-denaturing agent
07/30/2008EP1950300A2 Antibody variants with higher binding affinity compared to parent antibodies
07/30/2008EP1950299A1 Mammalian receptor proteins; related reagents and methods
07/30/2008EP1950292A1 Nato3, MARKER OF GROWING PROGENITOR CELL OF DOPAMINE-PRODUCING NEURON
07/30/2008EP1950281A1 Measuring device for determining the activity of a fermentation process
07/30/2008EP1950227A1 HYDROXYPROPYL-SULFOBUTYL-ß-CYCLODEXTRIN, THE PREPARATION METHOD,THE ANALYTICAL METHOD AND THE PHARMACUTICAL APPLICATION THEREOF
07/30/2008EP1950226A2 Receptors for human interleukin-12
07/30/2008EP1950222A1 Method for proving antibodies in body fluids via an immune reaction with glycoprotein 2 (GP2) from zymogen granula of the pancreas for a differential diagnosis of inflammable intestinal illnesses and chronic pancreatitis
07/30/2008EP1950221A2 Genomic sequences of exported mycobacteria polypeptides, vectors containing them and applications to the diagnosis and prevention of tuberculosis
07/30/2008EP1950207A1 Preparation of high purity phenothiazine n-alkylsulfonates and their use in chemiluminescent assays for the measurement of peroxidase activity
07/30/2008EP1949901A2 Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists
07/30/2008EP1949852A1 Detection of Disease by Analysis of Emissions
07/30/2008EP1949310A2 Apparatus and method for performing counts within a biologic fluid sample
07/30/2008EP1949110A2 Method for diagnosticating hepatic diseases and for screening molecules for treating said diseases
07/30/2008EP1949109A2 Peptide sequence that promotes tumor invasion
07/30/2008EP1949108A2 Modified cardiolipin and uses therefor
07/30/2008EP1949107A1 Negative immunomodulation of immune responses by nkg2d-positive cd4-positive cells
07/30/2008EP1949106A2 Detection unit, in particular biosensor, and use thereof
07/30/2008EP1949105A2 Diabetes-associated markers and methods of use thereof
07/30/2008EP1949104A2 Method of measuring the affinity of biomolecules
07/30/2008EP1949102A2 Assays